These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 10861826)

  • 1. Relapse after autologous hematopoietic stem cell transplantation in acute myeloid leukemia, a single center experience over 13 years.
    Lévy V; Marjanovic Z; Vekhoff A; Belhocine R; Marie JP; Delmer A; Ajchenbaum-Cymbalista F; Zittoun R; Rio B
    Am J Hematol; 2000 Jul; 64(3):232-3. PubMed ID: 10861826
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoimmune thrombocytopenia and neutropenia after autologous peripheral blood stem cell transplantation.
    Wahid FS; Cheong SK; Sivagengei K
    Acta Haematol; 2002; 107(4):237-8. PubMed ID: 12053154
    [No Abstract]   [Full Text] [Related]  

  • 3. Infectious complications after autologous hematopoietic stem cell transplantation: comparison of patients with acute myeloid leukemia, malignant lymphoma, and multiple myeloma.
    Auner HW; Sill H; Mulabecirovic A; Linkesch W; Krause R
    Ann Hematol; 2002 Jul; 81(7):374-7. PubMed ID: 12185506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic stem cell transplantation in acute promyelocytic leukemia, experience in Iran.
    Alimoghaddam K; Ghavamzadeh A; Jahani M; Jalali A; Jorjani H; Iravani M; Hamidieh AA; Mousavi A; Bahar B; Behfar M; Derakhshandeh R; Rostami S
    Arch Iran Med; 2011 Sep; 14(5):332-4. PubMed ID: 21888457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fludarabine containing regimen followed by autologous peripheral blood stem cell transplantation in unselected patients with acute myeloid leukemia: a single center experience.
    Mazza P; Amurri B; Palazzo G; Prudenzano A; Pricolo G; Stani L
    Haematologica; 2000 Feb; 85(2):222-4. PubMed ID: 10681741
    [No Abstract]   [Full Text] [Related]  

  • 6. A retrospective comparison of autologous and unrelated donor hematopoietic cell transplantation in myelodysplastic syndrome and secondary acute myeloid leukemia: a report on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Al-Ali HK; Brand R; van Biezen A; Finke J; Boogaerts M; Fauser AA; Egeler M; Cahn JY; Arnold R; Biersack H; Niederwieser D; de Witte T
    Leukemia; 2007 Sep; 21(9):1945-51. PubMed ID: 17611571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Outcome of Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Acute Myeloid Leukemia (AML)- Single Center Retrospective Analysis.
    Helbig G; Koclęga A; Woźniczka K; Kopera M; Kyrcz-Krzemień S
    Pathol Oncol Res; 2018 Jul; 24(3):469-475. PubMed ID: 28660547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infectious complication in 314 patients after high-dose therapy and autologous hematopoietic stem cell transplantation: risk factors analysis and outcome.
    Gil L; Styczynski J; Komarnicki M
    Infection; 2007 Dec; 35(6):421-7. PubMed ID: 17926001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous hematopoietic stem-cell transplantation for children with acute myeloid leukemia in first or second complete remission: a prognostic factor analysis.
    Godder K; Eapen M; Laver JH; Zhang MJ; Camitta BM; Wayne AS; Gale RP; Doyle JJ; Yu LC; Chen AR; Garvin JH; Sandler ES; Yeager AM; Edwards JR; Horowitz MM
    J Clin Oncol; 2004 Sep; 22(18):3798-804. PubMed ID: 15365077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics and outcomes of therapy-related myeloid neoplasms following autologous stem cell transplantation for multiple myeloma.
    Nadiminti K; Sidiqi MH; Meleveedu K; Alkhateeb HB; Hogan WJ; Litzow M; Patnaik M; Kumar S; Gertz M; Chen D; Shah MV
    Blood Cancer J; 2021 Mar; 11(3):63. PubMed ID: 33741897
    [No Abstract]   [Full Text] [Related]  

  • 11. Autologous stem cell transplantation as post-remission therapy in adult acute myelogenous leukemia: does platelet contamination of peripheral blood mobilized stem cell grafts influence the risk of leukemia relapse?
    Bruserud O; Foss B; Abrahamsen JF; Gjertsen BT; Ernst P
    J Hematother Stem Cell Res; 2000 Aug; 9(4):433-43. PubMed ID: 10982241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic stem cell transplantation following relapse post autologous stem cell transplantation in adult patients with acute myeloid leukemia: A retrospective analysis of 537 patients from the Acute Leukemia Working Party of the EBMT.
    Christopeit M; Labopin M; Gorin NC; Saraceni F; Passweg J; Forcade E; Maertens J; Van Lint MT; Bosi A; Niederwieser D; Ehninger G; Polge E; Mohty M; Nagler A
    Am J Hematol; 2018 Dec; 93(12):1532-1542. PubMed ID: 30218444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal mycobacteriosis in a patient with acute myeloid leukaemia after autologous peripheral blood stem cell transplantation.
    Inada T; Shirono K; Tsuda H
    Eur J Haematol; 1995 Mar; 54(3):205-6. PubMed ID: 7720845
    [No Abstract]   [Full Text] [Related]  

  • 14. Autologous bone marrow transplantation for patients with acute myeloblastic leukemia in relapse after autologous blood stem cell transplantation.
    de la Rubia J; Sanz GF; Martín G; Sempere A; Picón I; Carral A; Larrea L; Martínez J; Soler MA; Bonanad S; López F; Jarque I; Sanz MA
    Bone Marrow Transplant; 1996 Dec; 18(6):1167-73. PubMed ID: 8971390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Outcome of Autologous Hematopoietic Cell Transplantation in Adult Patients with Acute Myeloid Leukemia: Who May Benefit from Autologous Hematopoietic Cell Transplantation?
    Yoon JH; Kim HJ; Park SS; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS
    Biol Blood Marrow Transplant; 2017 Apr; 23(4):588-597. PubMed ID: 28089879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
    Visani G; Lemoli R; Tosi P; Martinelli G; Testoni N; Ricci P; Motta M; Gherlinzoni F; Leopardi G; Pastano R; Rizzi S; Piccaluga P; Isidori A; Tura S
    Bone Marrow Transplant; 1999 Sep; 24(5):467-72. PubMed ID: 10482929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved outcome with hematopoietic stem cell transplantation in a poor prognostic subgroup of patients with mixed-lineage-leukemia-rearranged acute leukemia: Results from a prospective, multi-center study.
    Wang Y; Liu QF; Qin YZ; Liu DH; Xu LP; Jiang B; Jiang Q; Dai M; Yu SJ; Jiang XM; Liu YR; Huang XJ
    Am J Hematol; 2014 Feb; 89(2):130-6. PubMed ID: 24122923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic stem cell transplantation for myelofibrosis with leukemic transformation: a study from the Myeloproliferative Neoplasm Subcommittee of the CMWP of the European Group for Blood and Marrow Transplantation.
    Alchalby H; Zabelina T; Stübig T; van Biezen A; Bornhäuser M; Di Bartolomeo P; Beelen D; Cahn JY; Dreger P; Schroyens W; de Witte T; Olavarria E; Kröger N;
    Biol Blood Marrow Transplant; 2014 Feb; 20(2):279-81. PubMed ID: 24201159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of autologous hematopoietic stem cell transplantation to prevent relapse of neuromyelitis optica.
    Matiello M; Pittock SJ; Porrata L; Weinshenker BG
    Arch Neurol; 2011 Jul; 68(7):953-5. PubMed ID: 21403004
    [No Abstract]   [Full Text] [Related]  

  • 20. Autologous stem cell transplantation versus chemotherapy for adult patients with acute myeloid leukemia in first remission: the BGMT Group experience.
    Reiffers J; Stoppa AM; Attal M; Michallet M; Marit G; Blaise D; Huguet F; Corront B; Cony-Makhoul P; Montastruc M
    Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):17-9. PubMed ID: 8099731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.